Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis

Autores
Yuen, Kevin C. J.; Johannsson, Gudmundur; Ho, Ken K. Y.; Miller, Bradley S.; Bergadá, Ignacio; Rogol, Alan D.
Año de publicación
2023
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers to consider testing for GHD in children, the signs and symptoms of GHD are not always so apparent in adults. Quality of life and metabolic health are often impacted in patients with GHD; thus, making an accurate diagnosis is important so that appropriate growth hormone (GH) replacement therapy can be offered to these patients. Screening and testing for GHD require sound clinical judgment that follows after obtaining a complete medical history of patients with a hypothalamic–pituitary disorder and a thorough physical examination with specific features for each period of life, while targeted biochemical testing and imaging are required to confirm the diagnosis. Random measurements of serum GH levels are not recommended to screen for GHD (except in neonates) as endogenous GH secretion is episodic and pulsatile throughout the lifespan. One or more GH stimulation tests may be required, but existing methods of testing might be inaccurate, difficult to perform, and can be imprecise. Furthermore, there are multiple caveats when interpreting test results including individual patient factors, differences in peak GH cut-offs (by age and test), testing time points, and heterogeneity of GH and insulin-like growth factor 1 assays. In this article, we provide a global overview of the accuracy and cut-offs for diagnosis of GHD in children and adults and discuss the caveats in conducting and interpreting these tests.
Fil: Yuen, Kevin C. J.. University of Arizona; Estados Unidos
Fil: Johannsson, Gudmundur. University of Gothenburg; Suecia
Fil: Ho, Ken K. Y.. University of New South Wales; Australia
Fil: Miller, Bradley S.. University of Minnesota; Estados Unidos
Fil: Bergadá, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina
Fil: Rogol, Alan D.. University of Virginia; Estados Unidos
Materia
Growth hormone deficiency
Children
Adult
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/256060

id CONICETDig_88233d6aeb8cca8a1bc38bd56b34778d
oai_identifier_str oai:ri.conicet.gov.ar:11336/256060
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosisYuen, Kevin C. J.Johannsson, GudmundurHo, Ken K. Y.Miller, Bradley S.Bergadá, IgnacioRogol, Alan D.Growth hormone deficiencyChildrenAdulthttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers to consider testing for GHD in children, the signs and symptoms of GHD are not always so apparent in adults. Quality of life and metabolic health are often impacted in patients with GHD; thus, making an accurate diagnosis is important so that appropriate growth hormone (GH) replacement therapy can be offered to these patients. Screening and testing for GHD require sound clinical judgment that follows after obtaining a complete medical history of patients with a hypothalamic–pituitary disorder and a thorough physical examination with specific features for each period of life, while targeted biochemical testing and imaging are required to confirm the diagnosis. Random measurements of serum GH levels are not recommended to screen for GHD (except in neonates) as endogenous GH secretion is episodic and pulsatile throughout the lifespan. One or more GH stimulation tests may be required, but existing methods of testing might be inaccurate, difficult to perform, and can be imprecise. Furthermore, there are multiple caveats when interpreting test results including individual patient factors, differences in peak GH cut-offs (by age and test), testing time points, and heterogeneity of GH and insulin-like growth factor 1 assays. In this article, we provide a global overview of the accuracy and cut-offs for diagnosis of GHD in children and adults and discuss the caveats in conducting and interpreting these tests.Fil: Yuen, Kevin C. J.. University of Arizona; Estados UnidosFil: Johannsson, Gudmundur. University of Gothenburg; SueciaFil: Ho, Ken K. Y.. University of New South Wales; AustraliaFil: Miller, Bradley S.. University of Minnesota; Estados UnidosFil: Bergadá, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Rogol, Alan D.. University of Virginia; Estados UnidosBioScientifica2023-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/256060Yuen, Kevin C. J.; Johannsson, Gudmundur; Ho, Ken K. Y.; Miller, Bradley S.; Bergadá, Ignacio; et al.; Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis; BioScientifica; Endocrine Connections; 12; 7; 4-2023; 1-192049-3614CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://ec.bioscientifica.com/view/journals/ec/12/7/EC-22-0504.xmlinfo:eu-repo/semantics/altIdentifier/doi/10.1530/EC-22-0504info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-11-26T08:57:27Zoai:ri.conicet.gov.ar:11336/256060instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-11-26 08:57:27.89CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis
title Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis
spellingShingle Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis
Yuen, Kevin C. J.
Growth hormone deficiency
Children
Adult
title_short Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis
title_full Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis
title_fullStr Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis
title_full_unstemmed Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis
title_sort Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis
dc.creator.none.fl_str_mv Yuen, Kevin C. J.
Johannsson, Gudmundur
Ho, Ken K. Y.
Miller, Bradley S.
Bergadá, Ignacio
Rogol, Alan D.
author Yuen, Kevin C. J.
author_facet Yuen, Kevin C. J.
Johannsson, Gudmundur
Ho, Ken K. Y.
Miller, Bradley S.
Bergadá, Ignacio
Rogol, Alan D.
author_role author
author2 Johannsson, Gudmundur
Ho, Ken K. Y.
Miller, Bradley S.
Bergadá, Ignacio
Rogol, Alan D.
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Growth hormone deficiency
Children
Adult
topic Growth hormone deficiency
Children
Adult
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers to consider testing for GHD in children, the signs and symptoms of GHD are not always so apparent in adults. Quality of life and metabolic health are often impacted in patients with GHD; thus, making an accurate diagnosis is important so that appropriate growth hormone (GH) replacement therapy can be offered to these patients. Screening and testing for GHD require sound clinical judgment that follows after obtaining a complete medical history of patients with a hypothalamic–pituitary disorder and a thorough physical examination with specific features for each period of life, while targeted biochemical testing and imaging are required to confirm the diagnosis. Random measurements of serum GH levels are not recommended to screen for GHD (except in neonates) as endogenous GH secretion is episodic and pulsatile throughout the lifespan. One or more GH stimulation tests may be required, but existing methods of testing might be inaccurate, difficult to perform, and can be imprecise. Furthermore, there are multiple caveats when interpreting test results including individual patient factors, differences in peak GH cut-offs (by age and test), testing time points, and heterogeneity of GH and insulin-like growth factor 1 assays. In this article, we provide a global overview of the accuracy and cut-offs for diagnosis of GHD in children and adults and discuss the caveats in conducting and interpreting these tests.
Fil: Yuen, Kevin C. J.. University of Arizona; Estados Unidos
Fil: Johannsson, Gudmundur. University of Gothenburg; Suecia
Fil: Ho, Ken K. Y.. University of New South Wales; Australia
Fil: Miller, Bradley S.. University of Minnesota; Estados Unidos
Fil: Bergadá, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina
Fil: Rogol, Alan D.. University of Virginia; Estados Unidos
description Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated or associated with additional pituitary hormone deficiencies. Although diminished height velocity and short stature are useful and important clinical markers to consider testing for GHD in children, the signs and symptoms of GHD are not always so apparent in adults. Quality of life and metabolic health are often impacted in patients with GHD; thus, making an accurate diagnosis is important so that appropriate growth hormone (GH) replacement therapy can be offered to these patients. Screening and testing for GHD require sound clinical judgment that follows after obtaining a complete medical history of patients with a hypothalamic–pituitary disorder and a thorough physical examination with specific features for each period of life, while targeted biochemical testing and imaging are required to confirm the diagnosis. Random measurements of serum GH levels are not recommended to screen for GHD (except in neonates) as endogenous GH secretion is episodic and pulsatile throughout the lifespan. One or more GH stimulation tests may be required, but existing methods of testing might be inaccurate, difficult to perform, and can be imprecise. Furthermore, there are multiple caveats when interpreting test results including individual patient factors, differences in peak GH cut-offs (by age and test), testing time points, and heterogeneity of GH and insulin-like growth factor 1 assays. In this article, we provide a global overview of the accuracy and cut-offs for diagnosis of GHD in children and adults and discuss the caveats in conducting and interpreting these tests.
publishDate 2023
dc.date.none.fl_str_mv 2023-04
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/256060
Yuen, Kevin C. J.; Johannsson, Gudmundur; Ho, Ken K. Y.; Miller, Bradley S.; Bergadá, Ignacio; et al.; Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis; BioScientifica; Endocrine Connections; 12; 7; 4-2023; 1-19
2049-3614
CONICET Digital
CONICET
url http://hdl.handle.net/11336/256060
identifier_str_mv Yuen, Kevin C. J.; Johannsson, Gudmundur; Ho, Ken K. Y.; Miller, Bradley S.; Bergadá, Ignacio; et al.; Diagnosis and testing for growth hormone deficiency across the ages: A global view of the accuracy, caveats, and cut-offs for diagnosis; BioScientifica; Endocrine Connections; 12; 7; 4-2023; 1-19
2049-3614
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://ec.bioscientifica.com/view/journals/ec/12/7/EC-22-0504.xml
info:eu-repo/semantics/altIdentifier/doi/10.1530/EC-22-0504
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv BioScientifica
publisher.none.fl_str_mv BioScientifica
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1849873198715240448
score 13.011256